查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
2018942

白色生物技术市场：2026-2032年全球市场预测（依产品类型、原料来源、生物类型、产品形态、技术、生产规模及最终用途划分）

White Biotechnology Market by Product Type, Feedstock Source, Organism Type, Product Form, Technology, Production Scale, End-Use - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，白色生物技术市场价值将达到 3,202.2 亿美元，到 2026 年将成长至 3,467.3 亿美元，到 2032 年将达到 5,673.6 亿美元，复合年增长率为 8.51%。

主要市场统计数据
基准年 2025 3202.2亿美元
预计年份：2026年 3467.3亿美元
预测年份：2032年 5673.6亿美元
复合年增长率 (%) 8.51%

对不断发展的白色生物技术趋势进行了简洁扼要而又全面的概述，涵盖了技术进步、不断变化的监管环境和战略挑战。

白色生物技术领域正处于一个转折点，创新、永续性和不断变化的监管环境在此交汇，重塑着该产业的价值链。本书总结了影响生物製程和生物基产品在不同产业中开发、生产和商业化方式的许多因素。随着相关人员日益重视低碳解决方案和循环经济，发酵、酵素催化和基因工程等技术的应用范围正从利基领域扩展到主流製造策略。

分子层次的创新、製程的密集化以及对永续性的需求，是如何重塑白色生物技术领域的产业价值炼和商业性重点的？

白色生物技术正经历一场变革，其驱动力来自分子生物学的快速发展、製程密度的不断提高以及对永续性的需求，这些因素正在改变各个工业领域的优先事项。合成生物学和CRISPR基因编辑技术正在加速客製化微生物和酵素的开发，从而拓展可生产的生化产品范围，并实现资源高效的生产管道。因此，企业正日益寻求整合的生物製程平台，将上游发酵、精准的酵素催化和精简的下游製程相结合，以缩短开发週期并提高单位产品的经济效益。

美国关税调整的连锁反应正在重建白色生物技术领域的筹资策略、生产基地和供应链的韧性。

美国关税政策的决定为白人生物技术生态系统中的生产商、供应商和买家带来了新的商业性复杂性。到2025年，这些政策的累积影响将反映在进口成本、供应链筹资策略和价格趋势的调整上，迫使企业重新评估其采购和製造地。为了因应某些生物基原料和半成品关税的提高，一些公司正在加快本地化生产，将关键加工流程迁回国内，或探索替代原材料来源，以减少对高关税商品的依赖。

细分市场洞察揭示了产品类型、加工技术、应用、最终用户和原材料选择如何塑造独特的策略路径。

深入的市场细分揭示了每种产品类型、技术、应用、最终用户和原材料选择的不同机会领域，从而影响研发重点和商业性策略。产品层面的细分涵盖胺基酸、生质燃料、生物製药、生质塑胶、酵素和维生素，以及L-离胺酸和L-苏氨酸、生物柴油和生质乙醇、单株抗体和重组蛋白、PHA和PLA生质塑胶、工业和特种酵素以及维生素C和E等子类别，每个类别都具有独特的技术和监管考量。这种产品多样性影响着下游製程的复杂性、监管管道以及客户接受产品的时间节点。

对全球各地白人生物技术策略的影响因素——采用模式、法规环境和业务重点——进行跨区域的概述。

区域趋势显示，美洲、欧洲、中东和非洲以及亚太地区的技术采纳、产能和政策环境呈现不同的发展轨迹，每个地区都展现出独特的商业性特征和营运考量。在美洲，下游製程创新、创业投资活动和强劲的机构投资者需求等优势，与该地区特有的原材料依赖性和对贸易政策的敏感性形成鲜明对比，而这些因素都会影响采购决策。这些趋势有利于那些能够将技术差异化与敏捷的供应链结构结合的公司。

成熟企业与创新者之间的竞争、伙伴关係与卓越营运如何塑造白色生物技术领域的领导地位？

白色生物技术领域的企业格局由成熟的工业参与企业、专业的生物工艺创新者和敏捷的Start-Ups组成，这三者共同造就了激烈的竞争和合作机会。成熟的化工和农业公司正利用其下游渠道和规模优势整合生物基产品线，而专业的生物技术公司则专注于酶工程、细胞培养优化和新型发酵渠道等平台能力，以抢占细分市场。这种两极化促使各公司寻求互补能力，从而促进策略伙伴关係、授权授权和定向收购。

经营团队可以采取切实可行的、高优先级的行动，以降低商业化风险、优化营运并加速采用生物基工业解决方案。

产业领导者应采取务实的措施，将科学研究潜力转化为永续的商业性成果，同时管控监管、供应链和政策风险。首先，他们应优先考虑模组化和灵活的生产设计，以便快速调整原材料投入和产品线，从而降低关税和原材料价格波动风险。其次，他们应投资于製程整合和下游加工能力，以降低单位成本和环境影响，使生物基替代品在经济和环境方面都对终端用户更具吸引力。

采用严谨的混合方法研究途径，结合与专家的直接访谈、技术文献综述和检验，以检验策略见解。

本研究结合专家访谈、技术文献综述和跨领域检验验证，整合了一手和二手研究方法，从而对白色生物技术领域的发展趋势提供了可靠且经过验证的检验。一手资料包括对研发负责人、製程工程师、采购经理和监管专家的结构化访谈。这些访谈提供了关于技术成熟度、供应链限制因素和客户采纳驱动因素的定性见解。除这些访谈外，还进行了实地考察和检验研讨会，以确保对技术细节的解读与实际应用相符。

整合技术、监管和营运因素，得出实现白色生物技术创新商业化的关键策略结论。

这个结论总结了决策者在应对不断变化的白色生物技术格局时需要关注的核心要点：技术效率的提升、监管和永续性驱动因素以及外部政策共同决定了哪些提案能够成功推广。那些兼具卓越技术、灵活製造地和完善的永续发展理念的企业，最有可能实现永续价值。此外，为了因应关税趋势和区域政策差异，企业还需要具备策略柔软性和积极主动的供应链管理能力，以保持竞争力。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 工业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 白色生物技术市场：依产品类型划分

  • 工业酵素
    • 碳水化合物消化酶
    • 蛋白酶
    • 脂肪酶
    • 氧化还原酶
  • 生化产品
    • 有机酸
    • 酒精饮料
    • 胺基酸
    • 生物表面活性剂
  • 生质燃料和生质能源
    • 生质乙醇
    • 生物丁醇
    • 沼气和生物甲烷
  • 生物聚合物
    • PLA
    • PHA
    • PBS
    • 淀粉混合物

第九章 白色生物技术市场：依原料来源划分

  • 糖和淀粉
    • 玉米
    • 甘蔗
  • 木质纤维素生物质
    • 农业残余物
    • 林业剩余物
    • 能源作物
  • 油脂
    • 植物油
    • 甘油
  • C1 和气态原料
    • CO2
    • 合成气
    • 甲烷
  • 废弃物和副产品
    • 乳清
    • 糖蜜
    • 食物废弃物
  • 藻类和海洋生物质
    • 微藻类
    • 海藻

第十章 白色生物技术市场：依生物类型划分

  • 细菌
    • 大肠桿菌
    • 芽孢桿菌属
    • 棒状桿菌属
  • 酵母菌
    • 酿酒酵母
    • 科马加塔埃拉·法菲伊
  • 丝状真菌
    • 曲菌属
    • 里氏木霉
  • 微藻类和蓝菌
    • 小球藻属
    • 螺旋藻（Altrospira）
  • 古菌

第十一章 白色生物技术市场：依产品类型划分

  • 液体
  • 粉末
  • 固定的

第十二章 白色生物技术市场：依技术划分

  • 下游製程技术
    • 细胞分离
    • 一级纯化
    • 纯化
    • 配方
    • 公共产业与回收利用
  • 发酵技术
    • 浸没式发酵
    • 固相发酵
    • 气体发酵
  • 全细胞生物催化剂
  • 基因工程与合成生物学

第十三章 白色生物技术市场：依生产规模划分

  • 实验室
  • 飞行员
  • 示范
  • 商业的

第十四章 白色生物技术市场：依最终用途划分

  • 饮食
    • 麵包製作
    • 乳製品
    • 酿造和蒸馏
    • 果汁和饮料
  • 清洁剂和清洁剂
    • 洗衣店
    • 洗碗
  • 动物饲料
    • 家禽
    • 反刍动物
  • 纸浆和造纸
    • 漂
    • 脱墨
  • 纺织品和皮革
    • 脱胶
    • 生物抛光
  • 化学塑料
    • 单体和中间体
    • 生质塑胶
  • 能源与公共产业
    • 乙醇厂
    • 沼气厂
  • 个人护理和化妆品
    • 护肤
    • 护髮

第十五章 白色生物技术市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十六章 白色生技市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十七章 白色生物技术市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十八章：美国白色生物技术市场

第十九章：中国的白色生物技术市场

第20章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • AB Enzymes GmbH
  • Archer Daniels Midland Company
  • Arzeda, Inc.
  • Avantium NV
  • BASF SE
  • Biocon Limited
  • Biomason, Inc.
  • Braskem SA
  • Buhler AG
  • Cargill, Incorporated
  • Clariant AG
  • Corbion NV
  • Covestro AG
  • DSM-Firmenich AG
  • DuPont de Nemours, Inc.
  • Evonik Industries AG
  • Genomatica, Inc.
  • Gevo, Inc.
  • Ginkgo Bioworks Holdings, Inc.
  • Ginkgo Bioworks Holdings, Inc.
  • Ingredion Incorporated
  • International Flavors & Fragrances Inc.
  • Jeneil BIoTech Inc.
  • Johnson Matthey plc
  • LanzaTech, Inc.
  • Lonza Group AG
  • NatureWorks LLC by PTT Global Chemical
  • Novonesis Group
  • Solugen, Inc.
  • Tate & Lyle PLC
Product Code: MRR-710B1F0AC6A9

The White Biotechnology Market was valued at USD 320.22 billion in 2025 and is projected to grow to USD 346.73 billion in 2026, with a CAGR of 8.51%, reaching USD 567.36 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 320.22 billion
Estimated Year [2026] USD 346.73 billion
Forecast Year [2032] USD 567.36 billion
CAGR (%) 8.51%

A concise yet comprehensive orientation to the evolving white biotechnology landscape that frames technical progress, regulatory shifts, and strategic imperatives

The white biotechnology sector is at an inflection point where innovation, sustainability, and evolving regulation intersect to reshape industrial value chains. This introduction synthesizes the forces that are redefining how biological processes and bio-based products are developed, produced, and commercialized across diverse industries. As industrial stakeholders increasingly prioritize low-carbon solutions and circularity, the role of fermentation, enzyme catalysis, and genetic engineering has expanded beyond niche applications into mainstream manufacturing strategies.

Throughout this summary, attention is placed on both technological advances and shifting market dynamics that influence decision-making for manufacturers, processors, and end users. Advances in cell culture and enzyme technology are improving process yields and enabling new product classes, while downstream processing innovations lower purification costs and reduce environmental footprints. Concurrently, regulatory frameworks and public procurement preferences are elevating sustainability credentials as a competitive differentiator.

The introduction sets the stage for deeper analysis by outlining the key themes that follow: transformative shifts in technology and policy, the implications of tariff actions, segmentation-driven insights across product and application categories, regional performance nuances, and practical recommendations for leaders seeking to convert scientific capability into commercial advantage.

How molecular innovations, process intensification, and sustainability imperatives are reorganizing industrial value chains and commercial priorities in white biotechnology

White biotechnology is undergoing transformative shifts driven by rapid advances in molecular biology, process intensification, and sustainability mandates that are altering industrial priorities across multiple sectors. Synthetic biology and CRISPR-enabled engineering are accelerating the development of bespoke microbes and enzymes, thereby expanding the palette of producible biochemicals and enabling resource-efficient pathways. As a result, companies are increasingly pursuing integrated bioprocess platforms that combine upstream fermentation, precision enzyme catalysis, and streamlined downstream processing to shorten development cycles and improve unit economics.

Concurrently, demand-side shifts are elevating biologically derived products in food, materials, and pharmaceuticals. Buyers are placing higher value on traceability, lower lifecycle emissions, and functional performance that matches or exceeds conventional alternatives. These expectations are catalyzing cross-sector partnerships between ingredient producers, formulators, and brand owners seeking to co-develop applications that can scale commercially. In addition, capital allocation patterns are tilting toward firms that demonstrate both technological differentiation and clear pathways to regulatory compliance, prompting consolidation and strategic alliances.

Taken together, these transformative shifts are converting laboratory breakthroughs into industrial options at pace, necessitating adaptive strategies that reconcile scientific potential with supply chain resilience and regulatory realities.

The ripple effects of United States tariff adjustments reshaping sourcing strategies, production footprints, and supply chain resilience in white biotechnology

Tariff policy decisions in the United States have introduced a new layer of commercial complexity for producers, suppliers, and buyers in the white biotechnology ecosystem. The cumulative impacts observed in 2025 reflect adjustments across import costs, supply chain sourcing strategies, and pricing dynamics that require enterprises to revisit procurement and manufacturing footprints. Higher duties on select bio-derived inputs and intermediate goods have prompted some firms to accelerate local production initiatives, repatriate critical processing steps, or seek alternative feedstock routes that reduce exposure to tariffed commodities.

As a consequence, companies with flexible process designs and modular manufacturing capabilities have been better positioned to mitigate added cost pressures through rapid reconfiguration of ingredient sourcing. Downstream processors and contract development and manufacturing organizations have seen an increased demand for localization services as clients prioritize tariff risk mitigation and continuity of supply. In parallel, purchasers have intensified supplier qualification criteria to incorporate tariff sensitivity analysis, total landed cost assessments, and contingency sourcing plans.

Importantly, the tariff-driven rebalancing has also amplified interest in vertical integration for actors that can secure feedstock availability and control conversion steps. Firms are therefore evaluating strategic investments that promote raw material resilience, reduce logistics exposure, and preserve margins while maintaining compliance with evolving trade and customs regimes.

Segment-specific intelligence revealing how product categories, processing technologies, applications, end users, and feedstock choices create distinct strategic pathways

Insightful segmentation reveals differentiated opportunity zones across product types, technologies, applications, end users, and feedstock choices that influence both R&D priorities and commercial approaches. Product-level distinctions span amino acids, biofuels, biopharmaceuticals, bioplastics, enzymes, and vitamins, with subcategories such as L-Lysine and L-Threonine, biodiesel and bioethanol, monoclonal antibodies and recombinant proteins, PHA and PLA bioplastics, industrial versus specialty enzymes, and vitamin C and vitamin E each presenting unique technical and regulatory considerations. These product variances shape downstream processing complexity, regulatory pathways, and customer adoption timelines.

On the technology axis, differentiation emerges between cell culture platforms, downstream separation science, enzyme engineering and immobilization, fermentation modalities, and genetic engineering approaches including CRISPR and recombinant DNA techniques. Each technological domain offers distinct levers for cost reduction, yield enhancement, and functionality expansion, and firms often combine multiple technologies to create competitive barriers. Application-driven segmentation covers food and beverages, household care and industrial cleaning, oil and gas interventions, paper and pulp treatments, and textiles and leather processing, where use-case specificity defines formulation requirements and performance benchmarks.

End-user distinctions among agriculture, animal feed, chemical manufacturing, cosmetics, and pharmaceuticals further refine commercialization strategies, as customers in each sector prioritize different attributes-such as shelf stability for cosmetics, regulatory dossiers for pharmaceuticals, or nutrient density for animal feed. Finally, feedstock selection among cassava, corn, sugarcane, and wheat influences sustainability narratives, supply chain risk profiles, and cost structures, underscoring the need for integrated product-to-feedstock planning that aligns technical feasibility with commercial demand.

A cross-regional synthesis of adoption patterns, regulatory environments, and operational priorities that govern white biotechnology strategies across global hubs

Regional dynamics demonstrate varied trajectories for adoption, production capacity, and policy environment across the Americas, Europe, Middle East & Africa, and Asia-Pacific, with each geography presenting distinct commercial contours and operational considerations. In the Americas, strengths in downstream processing innovation, venture capital activity, and strong institutional demand are contrasted with localized feedstock dependencies and trade policy sensitivities that shape sourcing decisions. These dynamics favor firms that can combine technical differentiation with agile supply chain configurations.

The Europe, Middle East & Africa region emphasizes regulatory rigor, sustainability reporting, and circular economy policies that create opportunities for bio-based materials and greener manufacturing processes. Producers and technology suppliers operating in this region must navigate harmonized regulatory frameworks and growing customer demand for transparency, which rewards firms that can demonstrate verifiable lifecycle improvements and compliance readiness. In contrast, the Asia-Pacific region is characterized by scale-driven manufacturing capabilities, rapidly expanding domestic demand for bio-derived ingredients, and diverse feedstock availability, encouraging investments in large-scale fermentation infrastructure and regional partnerships to meet both domestic and export-oriented needs.

Taken together, these regional contrasts indicate that successful actors tailor their market entry and growth strategies to local regulatory expectations, feedstock ecosystems, and customer priorities while retaining the flexibility to redeploy capabilities across geographies as commercial conditions evolve.

How competitive dynamics, partnerships, and operational excellence among incumbents and innovators are shaping leadership in white biotechnology

Company-level dynamics in white biotechnology emphasize a mix of incumbent industrial players, specialized bioprocess innovators, and agile start-ups that together define competitive intensity and collaboration opportunities. Established chemical and agricultural firms are leveraging their downstream channels and scale to integrate bio-based product lines, while specialist biotechnology companies concentrate on platform capabilities such as enzyme engineering, cell culture optimization, and novel fermentation pathways to capture niche value pools. This duality has encouraged strategic partnerships, licensing arrangements, and targeted acquisitions as firms seek complementary capabilities.

In addition, the investment landscape continues to support companies that demonstrate reproducible process performance and clear regulatory strategies. Strategic differentiation frequently arises from proprietary process know-how, robust intellectual property portfolios, and demonstrated supply chain partnerships that de-risk commercialization for large buyers. Contract development and manufacturing organizations are increasingly relevant as intermediaries that enable smaller innovators to scale without requiring heavy capital outlays.

Operational excellence, quality systems alignment with regulatory standards, and the ability to articulate verifiable sustainability metrics are common success factors among leading companies. Firms that combine technical depth with strong commercialization pathways and responsive customer engagement tend to outperform peers in attracting strategic partners and long-term off-take agreements.

Practical and prioritized actions that leadership teams can implement to de-risk commercialization, optimize operations, and accelerate adoption of bio-based industrial solutions

Industry leaders should adopt a pragmatic suite of actions to translate scientific potential into durable commercial outcomes while managing regulatory, supply chain, and policy risks. First, prioritize modular and flexible manufacturing designs that allow rapid adaptation of feedstock inputs and product lines to mitigate tariff exposure and feedstock volatility. Second, invest in process intensification and downstream processing capabilities to reduce unit costs and environmental impact, thereby making bio-based alternatives economically and ecologically compelling for end users.

Third, develop targeted partnerships across the value chain, including feedstock suppliers, contract manufacturers, and brand owners, to accelerate market access and share the capital burden of scale-up. Fourth, integrate regulatory and sustainability criteria into product development roadmaps from day one to shorten approval times and meet buyer expectations for transparent environmental performance. Additionally, strengthen intellectual property strategies that protect process innovations while enabling selective licensing where complementary partners can accelerate adoption.

Finally, embed advanced analytics and scenario planning into strategic decision-making so that leadership teams can stress-test supply chains, evaluate tariff scenarios, and identify priority markets for localized investment. By combining operational flexibility, collaborative commercialization models, and disciplined regulatory planning, companies can convert promising technologies into repeatable, profitable product lines.

A rigorous mixed-methods research approach integrating primary expert engagement, technical literature review, and triangulation to validate strategic insights

This research synthesizes primary and secondary methods to deliver a robust and validated perspective on white biotechnology dynamics, combining expert interviews, technical literature review, and cross-sector triangulation. Primary inputs include structured interviews with R&D leaders, process engineers, procurement heads, and regulatory specialists who provided qualitative insights into technology maturation, supply chain constraints, and customer adoption drivers. These conversations were complemented by site visit observations and validation workshops that ensured interpretation of technical details aligned with real-world practice.

Secondary research encompassed peer-reviewed journals, industry standards guidance, patent filings, and publicly available regulatory documentation to ensure technical assertions and policy interpretations were grounded in verifiable sources. Data triangulation techniques were applied to reconcile differing inputs and to surface consistent patterns across product segments and geographies. Quality assurance steps included independent expert review and iterative cross-checking of thematic conclusions to reduce bias and strengthen reproducibility.

Ethical considerations and transparency guided the methodology, with confidential inputs anonymized and proprietary information handled under agreed non-disclosure terms. This mixed-methods approach provides leaders with a defensible evidence base for strategic planning and operational prioritization in white biotechnology.

Key strategic conclusions that synthesize technological, regulatory, and operational levers critical for commercializing white biotechnology innovations

The conclusion encapsulates the central takeaways for decision-makers navigating the evolving white biotechnology landscape: technology-enabled efficiency gains, regulatory and sustainability drivers, and external policy actions collectively determine which propositions will scale successfully. Organizations that combine technical excellence with adaptive manufacturing footprints and integrated sustainability narratives are best positioned to capture enduring value. Moreover, tariff developments and regional policy differences require strategic flexibility and proactive supply chain management to preserve competitiveness.

Looking ahead, success will hinge on the ability to align product development with customer-specific performance metrics, to secure reliable feedstock channels, and to demonstrate credible lifecycle benefits that resonate with regulators and purchasers alike. Strategic collaborations, selective vertical integration, and disciplined intellectual property management will be powerful tools for firms seeking to bridge technical demonstration and commercial adoption. Ultimately, stakeholders who treat biological innovation as part of a broader systems transformation-incorporating procurement, regulatory strategy, and customer engagement-will accelerate adoption and create more resilient business models.

This synthesis should help leadership teams prioritize investments, structure partnerships, and design operational roadmaps that convert scientific capability into scalable, sustainable commercial outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. White Biotechnology Market, by Product Type

  • 8.1. Industrial Enzymes
    • 8.1.1. Carbohydrases
    • 8.1.2. Proteases
    • 8.1.3. Lipases
    • 8.1.4. Oxidoreductases
  • 8.2. Biochemicals
    • 8.2.1. Organic Acids
    • 8.2.2. Alcohols
    • 8.2.3. Amino Acids
    • 8.2.4. Biosurfactants
  • 8.3. Biofuels & Bioenergy
    • 8.3.1. Bioethanol
    • 8.3.2. Biobutanol
    • 8.3.3. Biogas & Biomethane
  • 8.4. Biopolymers
    • 8.4.1. PLA
    • 8.4.2. PHA
    • 8.4.3. PBS
    • 8.4.4. Starch Blends

9. White Biotechnology Market, by Feedstock Source

  • 9.1. Sugars & Starches
    • 9.1.1. Corn
    • 9.1.2. Sugarcane
  • 9.2. Lignocellulosic Biomass
    • 9.2.1. Agricultural Residues
    • 9.2.2. Forestry Residues
    • 9.2.3. Energy Crops
  • 9.3. Oils & Fats
    • 9.3.1. Vegetable Oils
    • 9.3.2. Glycerol
  • 9.4. C1 & Gas Substrates
    • 9.4.1. CO2
    • 9.4.2. Syngas
    • 9.4.3. Methane
  • 9.5. Waste & Side Streams
    • 9.5.1. Dairy Whey
    • 9.5.2. Molasses
    • 9.5.3. Food Waste
  • 9.6. Algal & Marine Biomass
    • 9.6.1. Microalgae
    • 9.6.2. Seaweed

10. White Biotechnology Market, by Organism Type

  • 10.1. Bacteria
    • 10.1.1. Escherichia coli
    • 10.1.2. Bacillus spp.
    • 10.1.3. Corynebacterium spp.
  • 10.2. Yeasts
    • 10.2.1. Saccharomyces cerevisiae
    • 10.2.2. Komagataella phaffii
  • 10.3. Filamentous Fungi
    • 10.3.1. Aspergillus spp.
    • 10.3.2. Trichoderma reesei
  • 10.4. Microalgae & Cyanobacteria
    • 10.4.1. Chlorella spp.
    • 10.4.2. Arthrospira (Spirulina)
  • 10.5. Archaea

11. White Biotechnology Market, by Product Form

  • 11.1. Liquid
  • 11.2. Powder
  • 11.3. Immobilized

12. White Biotechnology Market, by Technology

  • 12.1. Downstream Technology
    • 12.1.1. Cell Separation
    • 12.1.2. Primary Purification
    • 12.1.3. Polishing
    • 12.1.4. Formulation
    • 12.1.5. Utilities & Recovery
  • 12.2. Fermentation Technology
    • 12.2.1. Submerged Fermentation
    • 12.2.2. Solid-State Fermentation
    • 12.2.3. Gas Fermentation
  • 12.3. Whole-Cell Biocatalysis
  • 12.4. Genetic Engineering & Synthetic Biology

13. White Biotechnology Market, by Production Scale

  • 13.1. Lab
  • 13.2. Pilot
  • 13.3. Demonstration
  • 13.4. Commercial

14. White Biotechnology Market, by End-Use

  • 14.1. Food & Beverage
    • 14.1.1. Baking
    • 14.1.2. Dairy
    • 14.1.3. Brewing & Distilling
    • 14.1.4. Juices & Beverages
  • 14.2. Detergents & Cleaning
    • 14.2.1. Laundry
    • 14.2.2. Dishwashing
  • 14.3. Animal Nutrition
    • 14.3.1. Poultry
    • 14.3.2. Ruminants
  • 14.4. Pulp & Paper
    • 14.4.1. Bleaching
    • 14.4.2. Deinking
  • 14.5. Textiles & Leather
    • 14.5.1. Desizing
    • 14.5.2. Bio-Polishing
  • 14.6. Chemicals & Plastics
    • 14.6.1. Monomers & Intermediates
    • 14.6.2. Bioplastics
  • 14.7. Energy & Utilities
    • 14.7.1. Ethanol Plants
    • 14.7.2. Biogas Plants
  • 14.8. Personal Care & Cosmetics
    • 14.8.1. Skin Care
    • 14.8.2. Hair Care

15. White Biotechnology Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. White Biotechnology Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. White Biotechnology Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. United States White Biotechnology Market

19. China White Biotechnology Market

20. Competitive Landscape

  • 20.1. Market Concentration Analysis, 2025
    • 20.1.1. Concentration Ratio (CR)
    • 20.1.2. Herfindahl Hirschman Index (HHI)
  • 20.2. Recent Developments & Impact Analysis, 2025
  • 20.3. Product Portfolio Analysis, 2025
  • 20.4. Benchmarking Analysis, 2025
  • 20.5. AB Enzymes GmbH
  • 20.6. Archer Daniels Midland Company
  • 20.7. Arzeda, Inc.
  • 20.8. Avantium N.V.
  • 20.9. BASF SE
  • 20.10. Biocon Limited
  • 20.11. Biomason, Inc.
  • 20.12. Braskem S.A.
  • 20.13. Buhler AG
  • 20.14. Cargill, Incorporated
  • 20.15. Clariant AG
  • 20.16. Corbion N.V.
  • 20.17. Covestro AG
  • 20.18. DSM-Firmenich AG
  • 20.19. DuPont de Nemours, Inc.
  • 20.20. Evonik Industries AG
  • 20.21. Genomatica, Inc.
  • 20.22. Gevo, Inc.
  • 20.23. Ginkgo Bioworks Holdings, Inc.
  • 20.24. Ginkgo Bioworks Holdings, Inc.
  • 20.25. Ingredion Incorporated
  • 20.26. International Flavors & Fragrances Inc.
  • 20.27. Jeneil Biotech Inc.
  • 20.28. Johnson Matthey plc
  • 20.29. LanzaTech, Inc.
  • 20.30. Lonza Group AG
  • 20.31. NatureWorks LLC by PTT Global Chemical
  • 20.32. Novonesis Group
  • 20.33. Solugen, Inc.
  • 20.34. Tate & Lyle PLC

LIST OF FIGURES

  • FIGURE 1. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL WHITE BIOTECHNOLOGY MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL WHITE BIOTECHNOLOGY MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY FEEDSTOCK SOURCE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ORGANISM TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT FORM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY PRODUCTION SCALE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY END-USE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. UNITED STATES WHITE BIOTECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 15. CHINA WHITE BIOTECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY INDUSTRIAL ENZYMES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY INDUSTRIAL ENZYMES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY INDUSTRIAL ENZYMES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY INDUSTRIAL ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY CARBOHYDRASES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY CARBOHYDRASES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY CARBOHYDRASES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY PROTEASES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY PROTEASES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY PROTEASES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY LIPASES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY LIPASES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY LIPASES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY OXIDOREDUCTASES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY OXIDOREDUCTASES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY OXIDOREDUCTASES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOCHEMICALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOCHEMICALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOCHEMICALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOCHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ORGANIC ACIDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ORGANIC ACIDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ORGANIC ACIDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ALCOHOLS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ALCOHOLS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ALCOHOLS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY AMINO ACIDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY AMINO ACIDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY AMINO ACIDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOSURFACTANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOSURFACTANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOSURFACTANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOFUELS & BIOENERGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOFUELS & BIOENERGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOFUELS & BIOENERGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOFUELS & BIOENERGY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOETHANOL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOETHANOL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOETHANOL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOBUTANOL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOBUTANOL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOBUTANOL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOGAS & BIOMETHANE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOGAS & BIOMETHANE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOGAS & BIOMETHANE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOPOLYMERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOPOLYMERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOPOLYMERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOPOLYMERS, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY PLA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY PLA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY PLA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY PHA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY PHA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY PHA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY PBS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY PBS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY PBS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY STARCH BLENDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY STARCH BLENDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY STARCH BLENDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY FEEDSTOCK SOURCE, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY SUGARS & STARCHES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY SUGARS & STARCHES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY SUGARS & STARCHES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY SUGARS & STARCHES, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY CORN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY CORN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY CORN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY SUGARCANE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY SUGARCANE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY SUGARCANE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY LIGNOCELLULOSIC BIOMASS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY LIGNOCELLULOSIC BIOMASS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY LIGNOCELLULOSIC BIOMASS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY LIGNOCELLULOSIC BIOMASS, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY AGRICULTURAL RESIDUES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY AGRICULTURAL RESIDUES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY AGRICULTURAL RESIDUES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY FORESTRY RESIDUES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY FORESTRY RESIDUES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY FORESTRY RESIDUES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ENERGY CROPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ENERGY CROPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ENERGY CROPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY OILS & FATS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY OILS & FATS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY OILS & FATS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY OILS & FATS, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY VEGETABLE OILS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY VEGETABLE OILS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY VEGETABLE OILS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY GLYCEROL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY GLYCEROL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY GLYCEROL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY C1 & GAS SUBSTRATES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY C1 & GAS SUBSTRATES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY C1 & GAS SUBSTRATES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY C1 & GAS SUBSTRATES, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY CO2, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY CO2, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY CO2, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY SYNGAS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY SYNGAS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY SYNGAS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY METHANE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY METHANE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY METHANE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY WASTE & SIDE STREAMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY WASTE & SIDE STREAMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY WASTE & SIDE STREAMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY WASTE & SIDE STREAMS, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY DAIRY WHEY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY DAIRY WHEY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY DAIRY WHEY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY MOLASSES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY MOLASSES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY MOLASSES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY FOOD WASTE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY FOOD WASTE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY FOOD WASTE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ALGAL & MARINE BIOMASS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ALGAL & MARINE BIOMASS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ALGAL & MARINE BIOMASS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ALGAL & MARINE BIOMASS, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY MICROALGAE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY MICROALGAE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY MICROALGAE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY SEAWEED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY SEAWEED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY SEAWEED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ORGANISM TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BACTERIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BACTERIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BACTERIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BACTERIA, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ESCHERICHIA COLI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ESCHERICHIA COLI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ESCHERICHIA COLI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BACILLUS SPP., BY REGION, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BACILLUS SPP., BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BACILLUS SPP., BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY CORYNEBACTERIUM SPP., BY REGION, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY CORYNEBACTERIUM SPP., BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY CORYNEBACTERIUM SPP., BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY YEASTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY YEASTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY YEASTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY YEASTS, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY SACCHAROMYCES CEREVISIAE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY SACCHAROMYCES CEREVISIAE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY SACCHAROMYCES CEREVISIAE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY KOMAGATAELLA PHAFFII, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY KOMAGATAELLA PHAFFII, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY KOMAGATAELLA PHAFFII, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY FILAMENTOUS FUNGI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY FILAMENTOUS FUNGI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY FILAMENTOUS FUNGI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY FILAMENTOUS FUNGI, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ASPERGILLUS SPP., BY REGION, 2018-2032 (USD MILLION)
  • TABLE 163. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ASPERGILLUS SPP., BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ASPERGILLUS SPP., BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY TRICHODERMA REESEI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 166. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY TRICHODERMA REESEI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY TRICHODERMA REESEI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY MICROALGAE & CYANOBACTERIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 169. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY MICROALGAE & CYANOBACTERIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY MICROALGAE & CYANOBACTERIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY MICROALGAE & CYANOBACTERIA, 2018-2032 (USD MILLION)
  • TABLE 172. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY CHLORELLA SPP., BY REGION, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY CHLORELLA SPP., BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY CHLORELLA SPP., BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ARTHROSPIRA (SPIRULINA), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 176. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ARTHROSPIRA (SPIRULINA), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 177. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ARTHROSPIRA (SPIRULINA), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ARCHAEA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 179. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ARCHAEA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 180. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ARCHAEA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 182. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY LIQUID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 183. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY LIQUID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 184. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 185. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY POWDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 186. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY POWDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 187. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 188. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY IMMOBILIZED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 189. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY IMMOBILIZED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 190. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY IMMOBILIZED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 191. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 192. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY DOWNSTREAM TECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 193. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY DOWNSTREAM TECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 194. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY DOWNSTREAM TECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 195. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY DOWNSTREAM TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 196. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY CELL SEPARATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 197. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY CELL SEPARATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 198. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY CELL SEPARATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY PRIMARY PURIFICATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 200. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY PRIMARY PURIFICATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 201. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY PRIMARY PURIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY POLISHING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 203. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY POLISHING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 204. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY POLISHING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 205. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY FORMULATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 206. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY FORMULATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 207. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY FORMULATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY UTILITIES & RECOVERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 209. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY UTILITIES & RECOVERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 210. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY UTILITIES & RECOVERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 211. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY FERMENTATION TECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 212. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY FERMENTATION TECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 213. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY FERMENTATION TECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 214. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY FERMENTATION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 215. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY SUBMERGED FERMENTATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 216. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY SUBMERGED FERMENTATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 217. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY SUBMERGED FERMENTATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 218. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY SOLID-STATE FERMENTATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 219. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY SOLID-STATE FERMENTATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 220. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY SOLID-STATE FERMENTATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 221. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY GAS FERMENTATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 222. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY GAS FERMENTATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 223. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY GAS FERMENTATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 224. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY WHOLE-CELL BIOCATALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 225. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY WHOLE-CELL BIOCATALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 226. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY WHOLE-CELL BIOCATALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 227. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING & SYNTHETIC BIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 228. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING & SYNTHETIC BIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 229. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING & SYNTHETIC BIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 230. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY PRODUCTION SCALE, 2018-2032 (USD MILLION)
  • TABLE 231. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY LAB, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 232. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY LAB, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 233. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY LAB, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 234. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY PILOT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 235. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY PILOT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 236. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY PILOT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 237. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY DEMONSTRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 238. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY DEMONSTRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 239. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY DEMONSTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 240. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY COMMERCIAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 241. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY COMMERCIAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 242. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY COMMERCIAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 243. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY END-USE, 2018-2032 (USD MILLION)
  • TABLE 244. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY FOOD & BEVERAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 245. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY FOOD & BEVERAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 246. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY FOOD & BEVERAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 247. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY FOOD & BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 248. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BAKING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 249. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BAKING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 250. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BAKING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 251. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY DAIRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 252. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY DAIRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 253. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY DAIRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 254. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BREWING & DISTILLING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 255. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BREWING & DISTILLING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 256. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BREWING & DISTILLING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 257. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY JUICES & BEVERAGES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 258. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY JUICES & BEVERAGES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 259. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY JUICES & BEVERAGES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 260. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY DETERGENTS & CLEANING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 261. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY DETERGENTS & CLEANING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 262. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY DETERGENTS & CLEANING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 263. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY DETERGENTS & CLEANING, 2018-2032 (USD MILLION)
  • TABLE 264. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY LAUNDRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 265. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY LAUNDRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 266. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY LAUNDRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 267. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY DISHWASHING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 268. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY DISHWASHING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 269. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY DISHWASHING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 270. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ANIMAL NUTRITION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 271. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ANIMAL NUTRITION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 272. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ANIMAL NUTRITION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 273. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ANIMAL NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 274. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY POULTRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 275. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY POULTRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 276. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY POULTRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 277. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY RUMINANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 278. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY RUMINANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 279. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY RUMINANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 280. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY PULP & PAPER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 281. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY PULP & PAPER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 282. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY PULP & PAPER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 283. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY PULP & PAPER, 2018-2032 (USD MILLION)
  • TABLE 284. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BLEACHING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 285. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BLEACHING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 286. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BLEACHING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 287. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY DEINKING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 288. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY DEINKING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 289. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY DEINKING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 290. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY TEXTILES & LEATHER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 291. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY TEXTILES & LEATHER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 292. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY TEXTILES & LEATHER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 293. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY TEXTILES & LEATHER, 2018-2032 (USD MILLION)
  • TABLE 294. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY DESIZING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 295. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY DESIZING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 296. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY DESIZING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 297. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIO-POLISHING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 298. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIO-POLISHING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 299. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIO-POLISHING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 300. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY CHEMICALS & PLASTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 301. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY CHEMICALS & PLASTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 302. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY CHEMICALS & PLASTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 303. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY CHEMICALS & PLASTICS, 2018-2032 (USD MILLION)
  • TABLE 304. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY MONOMERS & INTERMEDIATES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 305. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY MONOMERS & INTERMEDIATES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 306. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY MONOMERS & INTERMEDIATES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 307. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOPLASTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 308. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOPLASTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 309. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOPLASTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 310. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ENERGY & UTILITIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 311. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ENERGY & UTILITIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 312. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ENERGY & UTILITIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 313. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ENERGY & UTILITIES, 2018-2032 (USD MILLION)
  • TABLE 314. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ETHANOL PLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 315. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ETHANOL PLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 316. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ETHANOL PLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 317. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOGAS PLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 318. GLOBAL WHITE